Moderna Inc (0QF.D.EB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [BXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [BXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 215,000 | 189,000 | 621,000 | 348,000 | 232,000 |
| Income taxes - deferred | N/A | N/A | 828,000 | -559,000 | N/A |
| Accounts receivable | 156,000 | 534,000 | 493,000 | 1,790,000 | -1,784,000 |
| Accounts payable and accrued liabilities | -92,000 | -69,000 | 13,000 | 240,000 | 204,000 |
| Other Working Capital | 233,000 | -78,000 | -139,000 | -3,455,000 | 990,000 |
| Other Operating Activity | -2,385,000 | -3,580,000 | -4,934,000 | 6,617,000 | 13,978,000 |
| Operating Cash Flow | $-1,873,000 | $-3,004,000 | $-3,118,000 | $4,981,000 | $13,620,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -192,000 | -1,051,000 | -707,000 | -400,000 | -284,000 |
| Net Acquisitions | 0 | 0 | -85,000 | N/A | N/A |
| Purchase Of Investment | -5,768,000 | -6,529,000 | -3,760,000 | -11,435,000 | -12,652,000 |
| Sale Of Investment | 7,916,000 | 9,529,000 | 8,781,000 | 6,699,000 | 4,443,000 |
| Purchase Sale Intangibles | -10,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | -23,000 | -40,000 | -30,000 |
| Investing Cash Flow | $1,946,000 | $1,949,000 | $4,206,000 | $-5,176,000 | $-8,523,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 600,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -22,000 | N/A | N/A | N/A | -140,000 |
| Common Stock Issued | 35,000 | 66,000 | 46,000 | 65,000 | 124,000 |
| Common Stock Repurchased | N/A | 0 | -1,153,000 | -3,329,000 | -857,000 |
| Other Financing Activity | -20,000 | -10,000 | -270,000 | -184,000 | 0 |
| Financing Cash Flow | $593,000 | $56,000 | $-1,377,000 | $-3,448,000 | $-873,000 |
| Exchange Rate Effect | 2,000 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 1,929,000 | 2,928,000 | 3,217,000 | 6,860,000 | 2,636,000 |
| End Cash Position | 2,597,000 | 1,929,000 | 2,928,000 | 3,217,000 | 6,860,000 |
| Net Cash Flow | $666,000 | $-999,000 | $-289,000 | $-3,643,000 | $4,224,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,873,000 | -3,004,000 | -3,118,000 | 4,981,000 | 13,620,000 |
| Capital Expenditure | -202,000 | -1,051,000 | -707,000 | -400,000 | -284,000 |
| Free Cash Flow | -2,075,000 | -4,055,000 | -3,825,000 | 4,581,000 | 13,336,000 |